CnT-PR-EN-HC
Frozen medium
500 mL
CHF 526.00
CnT‑PR‑EN‑HC is a serum‑free, clinically ready medium designed for class‑leading proliferation of primary human endothelial cells over extended periods. It supports high‑efficiency isolation and expansion and is well suited for product development, protocol validation, and characterization of cell‑based products.
The formulation is highly refined and based on an advanced basal medium supplemented with Progenitor Cell Targeted (PCT) growth factors, which extend cellular longevity, as well as co‑factors that enhance growth factor binding to membrane‑bound receptors. It does not contain phenol red or antibiotics/antimycotics.
For optimal performance, users are advised to supplement the medium with 2% serum appropriate for their clinical application.
To learn more, visit our webpage: Higher Certified Media
1
2
3
4
5
![[Fig. 1]. Primary HUVEC cells growing in the CnT-PR-EN medium at Passage 3](https://cellntec.com/wp-content/uploads/2026/03/HUVEC_PR-EN_450x600px-150x150-1.jpg)
![[Fig. 2]. Primary HUVEC cells demonstrate correct juntional localization of VE-Cadherin under both static and flow (1.4 Pa) conditions. Analysis courtesy of Georgios Stefanopoulos, Laboratory of Thermodynamics in Emerging Technologies, ETH Zurich.](https://cellntec.com/wp-content/uploads/2026/03/VE_Cadherin_450px-150x150-1.jpg)
![[Fig. 3]. Tube formation (microvascular-on-a-chip) and in vitro modeling of blood clotting by primary HUVEC cells grown in CELLnTEC’s endothelial medium (upper). Red: live cell staining. Green: Fluorochrom-labelled fibrinogen. Control: cells in EGM-2 medium (lower). Image courtesy of the Schroeder Group, Experimental Haemostasis, University of Bern.](https://cellntec.com/wp-content/uploads/2026/03/TubeFormation_CnT-Endo_EGM-2_400px-150x150-1.jpg)
